S&P Global (SPGI) and CME Group (CME) said Monday they have agreed to sell post-trade services provider OSTTRA to investment funds managed by KKR (KKR) in a deal giving OSTTRA an enterprise value of $3.1 billion.
OSTTRA is a joint venture between S&P Global and CME that was established in 2021.
KKR, which is investing in OSTTRA mainly through its North American private equity strategy, will support the business in creating a program to provide its employees the opportunity to participate in the benefits of ownership.
S&P Global and CME said the deal is expected to close in the H2, subject to regulatory approvals and other conditions.
S&P Global shares were up 1.2% in recent premarket activity, while CME rose 0.4%. KKR was up 1.3%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.